Fut, nem toborozFázis nélkül
Xeltis Peripheral Artery Disease (XPAD) Bypass Conduit Early Feasibility Study
A legfontosabb adatok
- Ki végzi
- Xeltis
- Hol
- Costa Rica1 helyszín, 1 országbanVálassz országot a helyszínekhez
- Azonosító
- Állapot
- Fut, nem toboroz
- Résztvevők
- 6 fő, tervezett
- Kezdés
- 2025. máj. 2.
- Várható befejezés
- 2028. dec.
- A vizsgálat típusa
- Beavatkozással járó
- A vizsgált kezelések
- Xeltis Peripheral Artery Disease (XPAD) Bypass Conduit
- A regiszteradat frissítve
- 2026. október 6.
Ki vehet részt
- Életkor
- 18 év felett
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter összes feltétele (27)A regiszter feltételeinek elrejtése
Ki vehet részt
- Subjects with femoral artery occlusion who require elective above-knee femoral popliteal bypass surgery
- Patient has Rutherford grade 3, 4, or 5 occlusive vascular disease and TASC C or D lesions. Rutherford grade 5 may be included with a wound, ischemia and foot infection (WiFi) classification of up to grade 2, provided there are two outflow vessels with at least one reaching the pedal arch
- At least 18 years of age at screening
- Suitable anatomy (assessed by a pre-procedural contrasted CT scan or previous angiogram assessed up to 90 days prior to baseline)
- Patient has been informed of the nature of the study, agrees to its provisions, and has provided written informed consent
- Patient has been informed and agrees to pre- and post-procedure follow-up, including follow-up angiography
- Life expectancy of at least 24 months
Ki nem vehet részt
- Stroke or myocardial infarction event within 6 weeks of the procedure or evidence of prior massive stroke (Modified Rankin Scale 3 or above)
- Previous renal transplant
- Previous enrolment in this study
- Unsuitable anatomy to implant the XPAD conduit (e.g. target vessel diameter smaller than anticipated; severe calcification)
- Subject requires, or is scheduled for, a cardiac surgical procedure or a different vascular surgical procedure within 30 days of study procedure
- Presence or history of bypass in the diseased limb
- History of acute arterial occlusion requiring an emergent intervention
- Uncontrolled arterial hypertension (BP >200 mmHg) at 2 successive readings
- Uncontrolled or poorly controlled diabetes
- Any active local or systemic infection
- Known active bleeding disorder and/or any coagulopathy or thromboembolic disease
- Allergies to study device (nitinol) or agents/medication, such as contrast agents or aspirin, that can't be controlled medically
- Any other condition which, in the judgement of the investigator would preclude adequate evaluation for the safety and performance of the study conduit; Intra-operative exclusion criteria:
- Severe chronic renal insufficiency (serum creatinine >2.5 mg/dL) or undergoing hemodialysis
- Reduced liver function, defined as: >2x the upper limit of normal for serum bilirubin, International Normalized Ratio (INR) >1.5 or prothrombin time (PT) >18 seconds
- Subject requires sequential extremity revascularizations or other procedures that require use of additional vascular grafts
- Abnormal blood values that could influence patient recovery and or/ graft hemostasis
- Known heparin-induced thrombocytopenia
- Subject is participating in another study
- Pregnant or breastfeeding woman or woman in fertile period not taking adequate contraceptives
Hol van ez a vizsgálat?
Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
A vizsgálatról
Mit akar kideríteni a vizsgálat
A prospective, single arm, non-randomized early feasibility study to evaluate the preliminary safety and performance of the XPAD conduit in patients with peripheral arterial occlusive disease (PAOD), scheduled to undergo elective above-knee femoral popliteal bypass surgery.
A vizsgálat csoportja
- XPAD Bypass ConduitA vizsgált kezelés
Kezelés: Xeltis Peripheral Artery Disease (XPAD) Bypass Conduit
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Prospective, Non-randomized, Early Feasibility Clinical Study to Assess the Feasibility of the Novel Xeltis Peripheral Artery Disease (XPAD) Bypass Conduit
- A regiszteradat frissítve
- 2026. október 6.